老年人口腔疾病中的多氨酸:一个范围审查
Stephanie Chu1, Alice Kit Ying Chan1, Chun Hung Chu1
1Faculty of Dentistry, The University of Hong Kong, Hong Kong 999077, China.
International journal of molecular sciences
|October 16, 2024
概括
聚氨酸,如精氨酸和氨酸,在患有口腔癌,牙周感染和口臭的老年人中是升高的. 这些化合物可以作为简单的生物标志物来检测和监测这些口腔疾病.
科学领域:
- 生物化学 生物化学
- 老年学是一门学科.
- 口腔医学是指口腔医学.
背景情况:
- 多氨酸调节细胞生长和功能,它们的不平衡与炎症和癌症有关.
- 聚氨酸的失调与各种病理状况有关.
研究的目的:
- 审查和总结现有的关于老年人口腔疾病中的多氨酸的文献.
- 探索聚氨酸作为口腔疾病的生物标志物的潜力.
主要方法:
- 从2000年1月到2024年5月的英语出版物的范围审查.
- 搜索的数据库包括MEDLINE,Scopus和科学网.
- 纳入标准集中在涉及65岁及以上成年人的临床和实验室研究上.
主要成果:
- 在患有口腔癌的老年人中发现了精氨酸水平的增加.
- 在老年患有牙周感染的成年人中观察到升高的普素水平.
- 在有口臭的老年人中,卡达维林含量更高,聚胺含量可能表明治疗成功.
结论:
- 在患有口腔癌,牙周感染和口臭的老年人中,特定的聚胺水平升高.
- 多氨酸显示出作为简单的,非侵入性生物标志物的潜力,用于早期检测和监测老年人口腔失生症.
相关概念视频
Drug Dosing: Geriatric Patients
395
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
395
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
354
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
354
Pharmacodynamics in Geriatric Patients: Effects of Age
367
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
367
Development of Human Microbiota
61
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
61
The Oral Microbiota
90
The oral microbiome includes a complex ecosystem comprising over 700 microbial species, identified through genomic sequencing and culture-based analyses to date. This community includes a core microbiome, found universally among individuals, and a variable component influenced by environmental factors such as diet, lifestyle, and host genetics. Site-specific conditions, including oxygen gradients, pH levels, and nutrient availability, determine the spatial distribution of these microorganisms...
90
Gut-Brain Axis
222
The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such...
222


